Literature DB >> 2646322

Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus.

N Suzuki1, T Sakane.   

Abstract

B cell hyperactivity present in the body in patients with systemic lupus erythematosus (SLE) can be detectable via almost any measure of B cell function. Nonetheless, the basis for the B cell hyperactivity is difficult to study in vitro. In this study, we have obtained the resting B cells from patients with entirely inactive SLE by collecting them sedimenting in a high density fraction on a Percoll density gradient. These resting SLE B cells proliferated in vitro at a higher rate than normal B cells when exposed to Staphylococcus aureus Cowan I (SAC). In addition, significant proliferation was observed earlier in the course of culture in SLE patients than in normal controls. Moreover, the SLE resting B cells, once triggered by SAC produced abnormally high numbers of immunoglobulin-secreting cells in response to T cell-derived soluble factors. There was less frequency of circulating Leu 1+ B cells in the SLE patients than in normal controls. Moreover, not only Leu 1+ B cells but also Leu 1- B cells of SLE patients were more responsive to SAC than those of normal controls. The results indicate that the B cell hyperactivity in human SLE can be induced by in vitro stimuli, and may not be limited to the Leu 1+ B cell subset.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646322      PMCID: PMC303769          DOI: 10.1172/JCI113979

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Immunoregulatory aberrations in systemic lupus erythematosus.

Authors:  A S Fauci; A D Steinberg; B F Haynes; G Whalen
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

2.  Adjuvant effects on poly I poly C in New Zealand mice.

Authors:  M E Jacobs; A D Steinberg; J K Gordon; N Talal
Journal:  Arthritis Rheum       Date:  1972 Mar-Apr

3.  Abnormal polyclonal B cell activation in NZB/NZW F1 mice.

Authors:  P L Cohen; M Ziff
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

4.  Impaired immunoglobulin synthesis by peripheral blood lymphocytes in systemic lupus erythematosus.

Authors:  K M Nies; J S Louie
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

5.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

6.  Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient.

Authors:  W Glinski; M E Gershwin; D R Budman; A D Steinberg
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

7.  Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate.

Authors:  Y Murakawa; T Sakane
Journal:  Arthritis Rheum       Date:  1988-07

8.  Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE.

Authors:  D R Budman; E B Merchant; A D Steinberg; B Doft; M E Gershwin; E Lizzio; J P Reeves
Journal:  Arthritis Rheum       Date:  1977-04

9.  In vitro TNP-specific antibody formation by peripheral lymphocytes from patients with systemic lupus erythematosus.

Authors:  C Morimoto; T Abe; M Hara; M Homma
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei.

Authors:  L L Vindelov
Journal:  Virchows Arch B Cell Pathol       Date:  1977-08-10
View more
  11 in total

1.  A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis.

Authors:  Sarah Bradshaw; W Jim Zheng; Lam C Tsoi; Gary Gilkeson; Xian K Zhang
Journal:  Clin Immunol       Date:  2008-08-09       Impact factor: 3.969

2.  Repeated exposure to bacterial lipopolysaccharide interferes with disposal of pathogenic immune complexes in mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.

Authors:  N Suzuki; T Sakane; E G Engleman
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Analysis of high and low responses to Staphylococcus aureus and interleukin 2 in human B lymphocytes.

Authors:  D W Peckham; D A Mower; R F Ashman
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

5.  Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.

Authors:  A Kitani; M Hara; T Hirose; M Harigai; K Suzuki; M Kawakami; Y Kawaguchi; T Hidaka; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

6.  Ongoing immunoglobulin class switch DNA recombination in lupus B cells: analysis of switch regulatory regions.

Authors:  Paolo Casali; Mary K Crow; Shiquan Liu; Andrea Cerutti
Journal:  Autoimmunity       Date:  2004 Sep-Nov       Impact factor: 2.815

Review 7.  B cell depletion therapy in systemic lupus erythematosus.

Authors:  Jennifer Anolik; Iñaki Sanz; R John Looney
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

8.  Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus.

Authors:  B K Pelton; M Speckmaier; W Hylton; J Farrant; A M Denman
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

9.  Precursor frequencies for DNA-specific B lymphocytes in patients with systemic lupus erythematosus (SLE).

Authors:  J Schwab; A Lukowsky; H D Volk; H H Peter; I Melchers
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

Review 10.  Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.

Authors:  Walaa Darwiche; Brigitte Gubler; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.